ReviewFrontiers in psychiatry2025
The prevalence of premenstrual syndrome in China: a systematic review and meta-analyses.
Review in Frontiers in psychiatry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Prevalence and severity of premenstrual tension syndrome and its impact on academic performance among female university students in Bangladesh: a cross-sectional study.BMC public health · 2026Article
- Global Burden of Premenstrual Syndrome and Uterine Fibroids in Women of Reproductive Age (1990-2023) and Projections to 2050: An Analysis of the Global Burden of Disease Study 2023.Health science reports · 2026Article
- Traditional Chinese Medical Care Application Patterns Among Nurses With Menstrual Symptoms: A Q Methodology Investigation.Nursing open · 2026Article
- Genetic predisposition for depression, psychosocial and behavioural factors and premenstrual symptoms: a cross-sectional study among young women in China.BMC medicine · 2026Article
- Premenstrual syndrome-related quality of life: associations with ultra-processed food consumption, mindful eating, well-being, and social media addiction in women.BMC women's health · 2026Article
- Global, regional, and national burden of premenstrual syndrome from 1990 to 2021 and projections to 2050: an analysis based on the 2021 Global Burden of Disease study.Frontiers in psychiatry · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Reliable estimates of the prevalence of premenstrual syndrome (PMS) serve as the basis for adequate prevention and treatment. However, the prevalence of PMS has rarely been synthesized at the Chinese level. We conducted this systematic review and meta-analyses to provide accurate and comprehensive evidence on the prevalence of PMS in China. Methods: PubMed, Web of Science, Embase, Cochrane Library, China National Knowledge Information, Chinese Scientific Journal (VIP), Wan fang and China Biology Medicine databases were systematically searched from inception until March 8, 2025. The prevalence of PMS in China was analyzed using a random effects model. Results: A total of 77 studies (108,178 participants) were included in the meta-analyses. The pooled prevalence of PMS in China was 48% (95% CI, 44-53%). Subgroup analyses revealed significant differences in the prevalence of PMS according to the screening tool, region, setting, and mean age. Meta-regression analyses indicated that using a prospective tool was significantly associated with lower prevalence. Limitations: There was a high degree of heterogeneity among the included studies; The included studies were conducted in urban areas; There was significant publication bias in this meta - analyses; Current meta-analyses contain insufficient information on many risk factors for PMS in China. Conclusion: The findings demonstrate that most Chinese women have PMS. Given the prevalence of PMS in China, future studies should explore its risk and protective factors, provide regular screening, and implement effective preventive and treatment measures for this demographic.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.